Brief: Abionyx Pharma And Sebia Announces Partnership To Transform Sepsis Diagnosis
20/11/2025 18:12
Nov 20 (Reuters) - Abionyx Pharma SA ABNX.PA: ABIONYX PHARMA AND SEBIA ANNOUNCE AN EXCLUSIVE GLOBAL STRATEGIC PARTNERSHIP TO TRANSFORM SEPSIS DIAGNOSIS ABIONYX PHARMA SA - PARTNERSHIP TO VALIDATE NEW TESTS FOR EARLY SEPSIS IDENTIFICATION ABIONYX PHARMA SA - FINANCIAL TERMS AND MILESTONES OF PARTNERSHIP REMAIN CONFIDENTIAL ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls